
Using high concentration biochemical assays and fragment-based screening assisted by structure-guided design, we discovered a novel class of Rho-kinase inhibitors. Compound 18 was equipotent for ROCK1 (IC(50) = 650 nM) and ROCK2 (IC(50) = 670 nM), whereas compound 24 was more selective for ROCK2 (IC(50) = 100 nM) over ROCK1 (IC(50) = 1690 nM). The crystal structure of the compound 18-ROCK1 complex revealed that 18 is a type 1 inhibitor that binds the hinge region in the ATP binding site. Compounds 18 and 24 inhibited potently the phosphorylation of the ROCK substrate MLC2 in intact human breast cancer cells.
Mitogen-Activated Protein Kinase 1, Models, Molecular, rho-Associated Kinases, Binding Sites, Mitogen-Activated Protein Kinase 3, Myosin Light Chains, Molecular Structure, Crystallography, X-Ray, Structure-Activity Relationship, Adenosine Triphosphate, Cell Line, Tumor, Humans, Phosphorylation, Cardiac Myosins
Mitogen-Activated Protein Kinase 1, Models, Molecular, rho-Associated Kinases, Binding Sites, Mitogen-Activated Protein Kinase 3, Myosin Light Chains, Molecular Structure, Crystallography, X-Ray, Structure-Activity Relationship, Adenosine Triphosphate, Cell Line, Tumor, Humans, Phosphorylation, Cardiac Myosins
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 52 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
